-
1
المؤلفون: David Schiff, Kurt A. Jaeckle, Evanthia Galanis, Kenneth Aldape, Donald Nordstrom, Stuart A. Grossman, Jeffrey S. Wefel, J. Gregory Cairncross, Michael A. Vogelbaum, Karla V. Ballman, F. Dhermain, Michael Weller, Martin Klein, Patrick J. Flynn, Wolfgang Wick, Paul D. Brown, S. Keith Anderson, Robert B. Jenkins, Caterina Giannini, Jesse G. Dixon, Jeffrey Raizer, Martin J. van den Bent, Jane H. Cerhan
المساهمون: Medical psychology, CCA - Cancer Treatment and quality of life, Neurology, Jaeckle K.A., Ballman K.V., Van Den Bent M., Giannini C., Galanis E., Brown P.D., Jenkins R.B., Cairncross J.G., Wick W., Weller M., Aldape K.D., Dixon J.G., Anderson S.K., Cerhan J.H., Wefel J.S., Klein M., Grossman S.A., Schiff D., Raizer J.J., Dhermain F., Nordstrom D.G., Flynn P.J., Vogelbaum M.A.
المصدر: Neuro-Oncology, 23(3), 457-467. Oxford University Press
Neuro Oncol
Jaeckle, K A, Ballman, K V, van den Bent, M, Giannini, C, Galanis, E, Brown, P D, Jenkins, R B, Cairncross, J G, Wick, W, Weller, M, Aldape, K D, Dixon, J G, Anderson, S K, Cerhan, J H, Wefel, J S, Klein, M, Grossman, S A, Schiff, D, Raizer, J J, Dhermain, F, Nordstrom, D G, Flynn, P J & Vogelbaum, M A 2021, ' CODEL : phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design ', Neuro-Oncology, vol. 23, no. 3, pp. 457-467 . https://doi.org/10.1093/neuonc/noaa168مصطلحات موضوعية: Oncology, Adult, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, N0577, Oligodendroglioma, Clinical Investigations, Brain Neoplasm, SDG 3 - Good Health and Well-being, Internal medicine, CODEL, Clinical endpoint, 1p/19q, Temozolomide, Medicine, Humans, Adverse effect, business.industry, Proportional hazards model, Brain Neoplasms, Hazard ratio, medicine.disease, Isocitrate Dehydrogenase, Progression-Free Survival, Radiation therapy, Dacarbazine, codeleted, Concomitant, Neurology (clinical), business, medicine.drug, Human
وصف الملف: STAMPA
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56e03eddb3cba1b719188e63344f8cb2
https://research.vumc.nl/en/publications/33bff83f-2fc1-46f7-ae8d-4b1d356f3369 -
2
المؤلفون: Anja Gijtenbeek, Martin J. van den Bent, Thierry Gorlia, C Mircea S Tesileanu, Peter Hau, Marc Sanson, Wolfgang Wick, Jean Francais Baurain, Roberta Rudà, Warren P. Mason, Walter Taal, Brigitta G. Baumert, Iris de Heer, Catherine McBain, Helen Wheeler, Sanjeev Gill, Vassilis Golfinopoulos, Elizabeth Lim, Pieter Wesseling, Jaap C. Reijneveld, Thierry Lesimple, Ulrich Herrlinger, Francesca Caparrotti, Roelien H. Enting, Olivier Chinot, Paul Clement, Sarah Erridge, Susan Clenton, Michael A. Vogelbaum, Johan M. Kros, Frédéric Dhermain, Alba A. Brandes, Hendrikus J. Dubbink, Kenneth Aldape, Matthew E. Griffin, Sarah Nuyens, Anna K. Nowak, Leland Rogers, Robert B. Jenkins, Pim J. French, Michael Weller
المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Radiotherapie, Institut de neurophysiopathologie (INP), Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Service d’Oncologie Médicale [Hôpital de la Timone - APHM], Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), Neurology, Pathology, CCA - Cancer Treatment and quality of life, CCA - Imaging and biomarkers
المصدر: Lancet oncology, 22(6), 813-823. Elsevier Science
van den Bent, M J, Tesileanu, C M S, Wick, W, Sanson, M, Brandes, A A, Clement, P M, Erridge, S, Vogelbaum, M A, Nowak, A K, Baurain, J F, Mason, W P, Wheeler, H, Chinot, O L, Gill, S, Griffin, M, Rogers, L, Taal, W, Rudà, R, Weller, M, McBain, C, Reijneveld, J, Enting, R H, Caparrotti, F, Lesimple, T, Clenton, S, Gijtenbeek, A, Lim, E, Herrlinger, U, Hau, P, Dhermain, F, de Heer, I, Aldape, K, Jenkins, R B, Dubbink, H J, Kros, J M, Wesseling, P, Nuyens, S, Golfinopoulos, V, Gorlia, T, French, P & Baumert, B G 2021, ' Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study ', The Lancet Oncology, vol. 22, no. 6, pp. 813-823 . https://doi.org/10.1016/S1470-2045(21)00090-5
Lancet Oncology
Lancet Oncology, 2021, 22 (6), pp.813-823. ⟨10.1016/S1470-2045(21)00090-5⟩
The Lancet Oncology, 22(6), 813-823. Lancet Publishing Group
The Lancet Oncology, 22(6), 813-823. ELSEVIER SCIENCE INC
Lancet Oncology, Elsevier, 2021, 22 (6), pp.813-823. ⟨10.1016/S1470-2045(21)00090-5⟩
Lancet Oncology, 22, 6, pp. 813-823
Lancet Oncology, 22, 813-823مصطلحات موضوعية: Male, Oncology, [SDV]Life Sciences [q-bio], medicine.medical_treatment, PROCARBAZINE, IDH2 MUTATIONS, Loss of Heterozygosity, Phases of clinical research, PROGRESSION, 0302 clinical medicine, EUROPEAN ORGANIZATION, ComputingMilieux_MISCELLANEOUS, education.field_of_study, Hazard ratio, Glioma, Middle Aged, Combined Modality Therapy, Isocitrate Dehydrogenase, 3. Good health, Dacarbazine, Europe, Chemotherapy, Adjuvant, Chromosomes, Human, Pair 1, 030220 oncology & carcinogenesis, Female, medicine.drug, Adult, medicine.medical_specialty, Adolescent, Population, Other Research Donders Center for Medical Neuroscience [Radboudumc 0], GLIOBLASTOMA, OLIGODENDROGLIAL TUMORS, CLASSIFICATION, LOMUSTINE, Young Adult, 03 medical and health sciences, Internal medicine, Temozolomide, medicine, Humans, VINCRISTINE, education, Aged, Chemotherapy, Performance status, business.industry, CENTRAL-NERVOUS-SYSTEM, Australia, Interim analysis, Radiation therapy, North America, Radiotherapy, Conformal, business, Chromosomes, Human, Pair 19, 030217 neurology & neurosurgery
وصف الملف: application/pdf
-
3
المؤلفون: Patrick Y. Wen, Susan M. Chang, Alfred Yung, Tracy T. Batchelor, Stuart A. Grossman, Lakshmi Nayak, Alice P. Chen, Timothy F. Cloughesy, Frank S. Lieberman, Antonio Omuro, Xiaobu Ye, Joy D. Fisher, Mark R. Gilbert, Lisa M. DeAngelis, Jeffrey S. Wefel, Jan Drappatz, Michael D. Prados, John de Groot, Kenneth Aldape
المصدر: Journal of neuro-oncology, vol 132, iss 1
مصطلحات موضوعية: Male, Vascular Endothelial Growth Factor A, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_treatment, Neuropsychological Tests, 0302 clinical medicine, Receptors, Adjuvant, Cancer, Aflibercept, Brain Neoplasms, Vascular Endothelial Growth Factor, Hematology, Glioma, Middle Aged, Alkylating, Combined Modality Therapy, Dacarbazine, Treatment Outcome, Neurology, Chemotherapy, Adjuvant, 6.1 Pharmaceuticals, 030220 oncology & carcinogenesis, Combination, Drug Therapy, Combination, Female, VEGF trap, medicine.drug, Adult, medicine.medical_specialty, Recombinant Fusion Proteins, Clinical Trials and Supportive Activities, Oncology and Carcinogenesis, Antineoplastic Agents, Neutropenia, Article, Vaccine Related, 03 medical and health sciences, Rare Diseases, Drug Therapy, Clinical Research, Internal medicine, Temozolomide, medicine, Chemotherapy, Humans, Oncology & Carcinogenesis, Antineoplastic Agents, Alkylating, Aged, business.industry, Neurosciences, Evaluation of treatments and therapeutic interventions, Newly diagnosed glioblastoma, medicine.disease, Brain Disorders, Surgery, Brain Cancer, Radiation therapy, Regimen, Orphan Drug, Receptors, Vascular Endothelial Growth Factor, 030104 developmental biology, Concomitant, Dose-dense, Neurology (clinical), business
وصف الملف: application/pdf
-
4
المؤلفون: Sheila Mansouri, Kelly Burrell, Alenoush Vartanian, Mark R. Wilson, Shahrzad Jalali, Peter D. Tonge, Amir Alamsahebpour, Michael S. Taccone, Kenneth Aldape, Sameer Agnihotri, Brian Golbourn, Gelareh Zadeh
المصدر: Oncotarget
مصطلحات موضوعية: Male, 0301 basic medicine, Cell signaling, MAP Kinase Signaling System, DNA damage, Dacarbazine, medicine.medical_treatment, Mice, SCID, 03 medical and health sciences, Mice, Inbred NOD, Cell Line, Tumor, Hexokinase, Temozolomide, medicine, Animals, Humans, cell signaling, Antineoplastic Agents, Alkylating, Cell Proliferation, Chemotherapy, Gene knockdown, Brain Neoplasms, business.industry, Cell growth, glioblastoma, Cancer, Chemoradiotherapy, medicine.disease, Xenograft Model Antitumor Assays, HEK293 Cells, 030104 developmental biology, Oncology, Immunology, Cancer research, novel treatments, RNA Interference, business, metabolism, DNA Damage, Research Paper, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::538195c280304daaf7a6e99b15f920af
https://doi.org/10.18632/oncotarget.11680 -
5
المؤلفون: Erica Hlavin Bell, Grant K. Hunter, Susan M. Chang, Helen A. Shih, Kenneth D. Aldape, Jean Paul Bahary, H. Ian Robins, Karl Belanger, Paul D. Brown, Minesh P. Mehta, Maria Werner-Wasik, Geoffrey R. Barger, Mark R. Gilbert, David Brachman, Kurt A. Jaeckle, Peixin Zhang, Christopher J. Schultz, Carol A. Dolinskas, Marta Penas-Prado, Arnab Chakravarti, J. Gregory Cairncross, David Schiff
المصدر: Neuro-oncology, vol 19, iss 2
مصطلحات موضوعية: Oncology, Male, Cancer Research, Nitrosourea, nitrosourea, medicine.medical_treatment, temozolomide, Nitrosourea Compounds, chemistry.chemical_compound, 0302 clinical medicine, 80 and over, Prospective Studies, Cancer, Aged, 80 and over, Tumor, Brain Neoplasms, anaplastic astrocytoma, Hazard ratio, Chemoradiotherapy, Middle Aged, Prognosis, Alkylating, Dacarbazine, Survival Rate, 030220 oncology & carcinogenesis, 6.1 Pharmaceuticals, Female, Corrigendum, medicine.drug, Adult, medicine.medical_specialty, Adolescent, Clinical Trials and Supportive Activities, Oncology and Carcinogenesis, Clinical Investigations, Antineoplastic Agents, Astrocytoma, 03 medical and health sciences, Young Adult, Rare Diseases, Clinical Research, Internal medicine, medicine, Biomarkers, Tumor, Temozolomide, Genetics, Humans, Oncology & Carcinogenesis, Survival rate, Antineoplastic Agents, Alkylating, radiotherapy, Neoplasm Staging, Aged, business.industry, Neurosciences, Evaluation of treatments and therapeutic interventions, medicine.disease, Carmustine, Brain Disorders, Radiation therapy, Brain Cancer, chemistry, Neurology (clinical), business, 030217 neurology & neurosurgery, Biomarkers, Anaplastic astrocytoma, Follow-Up Studies
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::691642fd38a32e75a654975ddb89b9e6
https://escholarship.org/uc/item/3zw2g691 -
6
المؤلفون: Robert Jeraj, Erik P. Sulman, Ivo W. Tremont-Lukats, Deborah T. Blumenthal, David Brachman, Kurt A. Jaeckle, Michael A. Vogelbaum, Terri S. Armstrong, James J. Dignam, Walter J. Curran, David Schiff, Kenneth Aldape, Minhee Won, Volker W. Stieber, Paul D. Brown, Minesh P. Mehta, Arnab Chakravarti, Maria Werner-Wasik, Jeffrey S. Wefel, Mark R. Gilbert, Howard Colman, Stephanie L. Pugh
المصدر: New England Journal of Medicine. 370:699-708
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Temozolomide, Bevacizumab, business.industry, medicine.medical_treatment, Dacarbazine, General Medicine, Placebo, Article, Surgery, law.invention, Radiation therapy, Clinical trial, Randomized controlled trial, law, Internal medicine, medicine, business, Survival analysis, medicine.drug
-
7
المؤلفون: James E. Herndon, John H. Sampson, Amy B. Heimberger, April Coan, Henry S. Friedman, Allan H. Friedman, Duane Mitchell, Darell D. Bigner, Mark R. Gilbert, Weiming Shi, Robert J. Schmittling, Kenneth D. Aldape, Annick Desjardins, Raymond Sawaya, David A. Reardon, James J. Vredenburgh, Gary E. Archer, Roger E. McLendon
المصدر: Neuro-Oncology. 13:324-333
مصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, T-Lymphocytes, medicine.medical_treatment, Dacarbazine, Clinical Investigations, T-Lymphocytes, Regulatory, Cohort Studies, Immunoenzyme Techniques, O(6)-Methylguanine-DNA Methyltransferase, Immune system, Lymphopenia, Internal medicine, Temozolomide, Humans, Medicine, Hypersensitivity, Delayed, Progression-free survival, Antineoplastic Agents, Alkylating, Survival rate, Aged, Aged, 80 and over, Chemotherapy, Brain Neoplasms, business.industry, DNA Methylation, Middle Aged, Chemotherapy regimen, ErbB Receptors, Survival Rate, Treatment Outcome, Chemotherapy, Adjuvant, Delayed hypersensitivity, Mutation, Vaccines, Subunit, Immunology, Female, Neurology (clinical), Glioblastoma, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7765a840d3ea25eac8507284fbe585e0
https://doi.org/10.1093/neuonc/noq157 -
8
المؤلفون: Wei Sun, John H. Sampson, Kenneth Aldape, Raymond Sawaya, Mark R. Gilbert, Lamonne M. Crutcher, Duane Mitchell, Darell D. Bigner, Mahua Dey, S. Farzana Hussain, Amy B. Heimberger, Samuel J. Hassenbusch, Gary E. Archer, Bob Schmittling
المصدر: Neuro-Oncology. 10:98-103
مصطلحات موضوعية: Male, Oncology, Cancer Research, medicine.medical_specialty, Case Studies/Case Illustration, T-Lymphocytes, medicine.medical_treatment, Dacarbazine, Active immunotherapy, Cancer Vaccines, T-Lymphocyte Subsets, Glioma, Internal medicine, Temozolomide, medicine, Humans, Antineoplastic Agents, Alkylating, Chemotherapy, Radiotherapy, Brain Neoplasms, business.industry, Immunotherapy, Middle Aged, Flow Cytometry, medicine.disease, Combined Modality Therapy, Chemotherapy regimen, ErbB Receptors, Vaccines, Subunit, Immunology, Peptide vaccine, Neurology (clinical), Glioblastoma, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cbdff42f3c89a94bdb884686688e084
https://doi.org/10.1215/15228517-2007-046 -
9
المؤلفون: Walter J. Curran, Minhee Won, Stephanie L. Pugh, Mark R. Gilbert, Jeffrey S. Wefel, Roger Stupp, Terri S. Armstrong, Kenneth Aldape, James J. Dignam, Monika E. Hegi, Minesh P. Mehta
المساهمون: University of Zurich
المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(15)
مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, MEDLINE, 610 Medicine & health, law.invention, Quality of life, Randomized controlled trial, law, Internal medicine, Post-hoc analysis, medicine, Humans, 1306 Cancer Research, Dosing, Antineoplastic Agents, Alkylating, Temozolomide, business.industry, Brain Neoplasms, Incidence (epidemiology), Surgery, Radiation therapy, Dacarbazine, Oncology, 10032 Clinic for Oncology and Hematology, 2730 Oncology, Female, business, Glioblastoma, medicine.drug
وصف الملف: JCO 0525 response to Chamberlain letter 4-22-14.pdf - application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edb8a59966c25ab552f871af8ba35dfc
https://pubmed.ncbi.nlm.nih.gov/24752051 -
10
المؤلفون: Monika E. Hegi, Meihua Wang, Brigitta G. Baumert, Kristen I. Hopkins, Mark R. Gilbert, Walter J. Curran, Jeffrey S. Wefel, Arnab Chakravarti, Roger Stupp, Christopher J. Schultz, Kenneth Aldape, Paul D. Brown, Minesh P. Mehta, Kurt A. Jaeckle, Minhee Won, Terri S. Armstrong, Anita Mahajan, Tzahala Tzuk-Shina, Sara Erridge, Deborah T. Blumenthal
المساهمون: University of Zurich, Gilbert, Mark R, Radiotherapie, RS: GROW - School for Oncology and Reproduction
المصدر: Journal of Clinical Oncology, 31(32), 4085-4091. American Society of Clinical Oncology
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Dacarbazine, medicine.medical_treatment, 610 Medicine & health, law.invention, Randomized controlled trial, law, Internal medicine, Original Reports, Clinical endpoint, medicine, 1306 Cancer Research, Temozolomide, business.industry, Surgery, Clinical trial, Radiation therapy, Concomitant, 10032 Clinic for Oncology and Hematology, 2730 Oncology, business, Chemoradiotherapy, medicine.drug
وصف الملف: Gilbert_RTOG0525_ddTMZ_JCO'13.pdf - application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a436b5971f4feeef0d20cda31367790
https://europepmc.org/articles/PMC3816958/